Cargando…

Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection initiates with viral entry in the upper respiratory tract, leading to coronavirus disease 2019 (COVID-19). Severe COVID-19 is characterized by pulmonary pathologies associated with respiratory failure. Thus, therapeutics aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizvi, Zaigham Abbas, Tripathy, Manas Ranjan, Sharma, Nishant, Goswami, Sandeep, Srikanth, N, Sastry, J. L. N., Mani, Shailendra, Surjit, Milan, Awasthi, Amit, Dikshit, Madhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551705/ https://www.ncbi.nlm.nih.gov/pubmed/34721035 http://dx.doi.org/10.3389/fphar.2021.746729

Ejemplares similares

Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2022)

Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2023)

Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2023)

Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2022)

Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
por: Shrivastava, Tripti, et al.
Publicado: (2021)

G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters
por: Roy, Shuvra Shekhar, et al.
Publicado: (2023)

IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation
por: Sadhu, Srikanth, et al.
Publicado: (2023)

High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2021)

Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach
por: Khatri, Ritika, et al.
Publicado: (2022)

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection
por: Supramaniam, Aroon, et al.
Publicado: (2023)

Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation
por: Roy, Suyasha, et al.
Publicado: (2019)

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
por: Safronetz, David, et al.
Publicado: (2011)

Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of stem cell therapy
por: Srikanth, G, et al.
Publicado: (2009)

Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat
por: Singh, Vishal, et al.
Publicado: (2015)

Liquid–liquid phase transition in deeply supercooled Stillinger–Weber silicon
por: Goswami, Yagyik, et al.
Publicado: (2022)

Design and Efficacy of Nanogels Formulations for Intranasal Administration
por: Aderibigbe, Blessing A., et al.
Publicado: (2018)

Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule
por: Agrahari, Ashish Kumar, et al.
Publicado: (2022)

RNA-Protein Interaction Analysis of SARS-CoV-2 5′ and 3′ Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection
por: Verma, Rohit, et al.
Publicado: (2021)

Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19
por: Binayke, Akshay, et al.
Publicado: (2022)

Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters
por: Wouters, Elise, et al.
Publicado: (2023)

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
por: Phua, Kyle K. L., et al.
Publicado: (2014)

Minimal persistent inflammation in Japanese cedar pollinosis and a prophylactic effect of intranasal corticosteroids
por: Noyama, Yasuyuki, et al.
Publicado: (2013)

Determining an Appropriate Time to Start Prophylactic Treatment with Intranasal Corticosteroids in Japanese Cedar Pollinosis
por: Haruna, Takenori, et al.
Publicado: (2019)

Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
por: Vishwakarma, Preeti, et al.
Publicado: (2021)

Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion
por: Patel, Mikesh B., et al.
Publicado: (2012)

Volume-Associated Clinical and Histopathological Effects of Intranasal Instillation in Syrian Hamsters: Considerations for Infection and Therapeutic Studies
por: Forero, Catalina, et al.
Publicado: (2022)

Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters
por: Liu, Shufeng, et al.
Publicado: (2022)

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
por: Baldeon Vaca, Gabriela, et al.
Publicado: (2023)

Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
por: Langel, Stephanie N., et al.
Publicado: (2022)

Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress
por: Renicker, Micah D., et al.
Publicado: (2018)

Prophylactic effect of intranasal oxytocin on brain damage and neurological disorders in global cerebral ischemia in mice
por: Saffari, Marzieh, et al.
Publicado: (2021)

Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome — After Intranasal Exposure to Andes Virus
por: Ogg, Monica, et al.
Publicado: (2013)

Intranasal Vaccination with Leishmanial Antigens Protects Golden Hamsters (Mesocricetus auratus) Against Leishmania (Viannia) braziliensis Infection
por: da Silva-Couto, Luzinei, et al.
Publicado: (2015)

Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2
por: Monchatre-Leroy, Elodie, et al.
Publicado: (2021)

Establishment of a Nipah Virus Disease Model in Hamsters, including a Comparison of Intranasal and Intraperitoneal Routes of Challenge
por: Findlay-Wilson, Stephen, et al.
Publicado: (2023)

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
por: Zhang, Liang, et al.
Publicado: (2023)

Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters
por: Gallardo-Toledo, Eduardo, et al.
Publicado: (2023)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
por: Al Asmari, Abdulrahman K, et al.
Publicado: (2016)

Preventing airborne infection with an intranasal cellulose powder formulation (Nasaleze Travel®)
por: Hiltunen, Raimo, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4l7toq6bst3p2t5e37s0c8gfa2